Description
Introduction
Sterility testing is carried out to confirm that products are free from microorganisms. It is imperative for medical devices, vaccines, pharmaceuticals, preparations, tissue materials, and other materials to be tested for sterility. Sterilization can be carried out in various ways including heat, chemicals, irradiation, high pressure, and filtration. Sterilization is similar to disinfection, sanitization, and pasteurization. In the sterilization process, microorganisms are either killed or are made inactive while biological agents are also eliminated. Most medical and surgical devices used in the pharmaceuticals industry are made of materials that are heat stable and therefore undergo heat, primarily steam, sterilization. However, increasingly, medical devices and instruments are being made of materials that require low-temperature sterilization.
The prevalence of chronic and highly communicable diseases such as AIDS is a major driver for market growth. The other factors responsible for market growth are innovation in drugs and government initiatives.
However, strict regulatory bodies and stringent regulatory policies are expected to restrain market growth during the forecast period.
The global sterility testing market has been segmented by product type, test type, and end user.
The global sterility testing market has been divided, by product type, into instrument, consumable, and services.
Based on test type, the global sterility testing market has been categorized as membrane filtration, direct transfer sterility testing, and product flush sterility testing.
On the basis of end user, the market has been classified as hospitals and clinics, pharmaceuticals industry, and academics and research laboratories
The global sterility testing market was valued at USD 540.1 million in 2017 and is expected to register a CAGR of 11.10% during the forecast period of 2018 to 2023.
Key Players
Some of the key players in the global sterility testing market are Merck KGaA (Germany), Pacific BioLabs Inc (US), Belimed Deutschland GmbH (Germany), Boston Scientific Corporation (US), Charles River Laboratories Inc. (US), Sartorius AG (Germany), BioMérieux SA (France), Baxter BioPharma Solutions (US), Astell Scientific (UK), SGS SA (Switzerland), Thermo Fisher Scientific Inc. (US), Becton Dickinson and Company (US), WuXi AppTec (China), Bioquell UK Ltd (UK), and Azbil Telstar SL (Spain).
Objectives of the Study
• To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global sterility testing market
• To provide insights into factors influencing and affecting market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries
• To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global sterility testing market
• To provide a detailed analysis of the value chain and supply chain of the global sterility testing market
Target Audience
• Biotechnological Institutes
• Research and Development Companies
• Medical Research Laboratories
• Market Research and Consulting Service Providers
• Pharmaceutical Companies
Key Findings
• The global sterility testing market is expected to reach USD 942.5 million by 2023 at a CAGR of 11.10% from 2018 to 2023.
• On the basis of test type, the membrane filtration segment accounted for the largest market share of 9.8% in 2017 and was valued at USD 350.7 million by 2023.
• The market in the Americas is expected to account for the largest share of the global sterility testing market and is projected to reach USD 520 million by 2023.
• The market in Asia-Pacific is projected to be the fastest-growing at a CAGR of 7.5% from 2018 to 2023.
Regional Analysis
• Americas
o North America
US
Canada
o Latin America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa
Table of Contents
Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Assumptions & Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing demand for sterile drugs for the treatment of medical conditions such as cancer,
cardiovascular diseases, and others
4.2.2 Growing pharmaceutical and biotechnology sector provides suitable backgrounds for the market growth
4.2.3 Increasing government funding in the medical sector
4.2.4 Rising investments in life sciences
4.2.5 Drivers Impact Analysis
4.3 Restraints
4.3.1 High cost of sterility tests
4.3.2 Prolonged storage of perishable pharmaceutical products and need of trained professionals
4.3.3 Restraints Impact Analysis
4.4 Opportunity
4.4.1 Untapped markets of the Asia Pacific region
4.5 Mega Trends
4.5.1 Increasing adoption of rapid sterility testing
4.6 Macroeconomic Indicator
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D & Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review
5.2 Porter’s Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
6 Global Sterility Testing Market, by Product Type
6.1 Introduction
6.2 Instruments
6.3 Consumables
6.4 Services
7 Global Sterility Testing Market, by Test Type
7.1 Introduction
7.2 Membrane Filtration Sterility Testing
7.3 Direct Transfer Sterility Testing
7.4 Product Flush Sterility Testing
8 Global Sterility Testing Market, by End User
8.1 Introduction
8.2 Pharmaceutical Companies
8.3 Hospital & Clinics
8.4 Academic & Research Laboratories
9 Global Sterility Testing Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 U.K
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest of Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Middle East & Africa
9.6 Middle East
9.6.1 Africa
10 Competitive Landscape
10.1 Competitive Landscape
10.2 Competitive Landscape
10.2.1 Introduction
11 Company Profiles
11.1 Merck KGaA
11.1.1 Company Overview
11.1.2 Products Offering
11.1.3 Key Developments
11.1.4 SWOT Analysis
11.1.5 Key Strategy
11.2 Pacific BioLabs Inc.
11.2.1 Company Overview
11.2.2 Products Offering
11.2.3 Key Developments
11.2.4 SWOT Analysis
11.3 Belimed Deutschland GmbH
11.3.1 Company Overview
11.3.2 Products Offering
11.3.3 Key Developments
11.3.4 SWOT Analysis
11.3.5 Key Strategy
11.4 Boston Scientific Corporation
11.4.1 Company Overview
11.4.2 Products Offering
11.4.3 Key Developments
11.4.4 SWOT Analysis
11.4.5 Key Strategy
11.5 Charles River Laboratories Inc.
11.5.1 Company Overview
11.5.2 Products Offering
11.5.3 Key Developments
11.5.4 SWOT Analysis
11.5.5 Key Strategy
11.6 Sartorius AG
11.6.1 Company Overview
11.6.2 Products Offering
11.6.3 Key Developments
11.6.4 SWOT Analysis
11.6.5 Key Strategy
11.7 BioMérieux SA
11.7.1 Company Overview
11.7.2 Products Offering
11.7.3 Key Developments
11.7.4 SWOT Analysis
11.7.5 Key Strategy
11.8 Baxter BioPharma Solutions
11.8.1 Company Overview
11.8.2 Products Offering
11.8.3 Key Developments
11.8.4 SWOT Analysis
11.8.5 Key Strategy
11.9 Astell Scientific
11.9.1 Company Overview
11.9.2 Products Offering
11.9.3 SWOT Analysis
11.1 SGS SA
11.10.1 Company Overview
11.10.2 Products Offering
11.10.3 Key Developments
11.10.4 SWOT Analysis
11.10.5 Key Strategy
11.11 Thermo Fisher Scientific Inc.
11.11.1 Company Overview
11.11.2 Products Offering
11.11.3 Key Developments
11.11.4 SWOT Analysis
11.11.5 Key Strategy
11.12 Becton, Dickinson and Company
11.12.1 Company Overview
11.12.2 Products Offering
11.12.3 Key Developments
11.12.4 SWOT Analysis
11.12.5 Key Strategy
11.13 WuXi AppTec
11.13.1 Company Overview
11.13.2 Products Offering
11.13.3 Key Developments
11.13.4 SWOT Analysis
11.14 Bioquell UK Ltd
11.14.1 Company Overview
11.14.2 Products Offering
11.14.3 SWOT Analysis
11.15 Azbil Telstar S.L.
11.15.1 Company Overview
11.15.2 Products Offering
11.15.3 SWOT Analysis
12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.2 Key Companies to Watch
13 Appendix
13.1 Discussion Blue Print
13.2 Recent Developments, 2013–2017
